Researchers have found that the lncRNA SLC16A1-AS1 forms an RNA–protein complex with transcription factor E2F1, which enhances metabolic reprogramming and invasiveness of bladder cancer by promoting the expression of SLC16A1/MCT1 (Logotheti et al., 2020). This evidence concerns the gene SLC16A1 and urinary bladder cancer.